Surrozen (NASDAQ:SRZN) Major Shareholder Tcg Crossover Gp Ii, Llc Purchases 15,223 Shares

March 26, 2026 by InsiderTrades.com

Key Points

TCG Crossover GP II executed a string of insider buys in March — notably 106,658 shares on Mar 24 for about $2.63M and 15,223 shares on Mar 23 for about $379k — signaling continued accumulation at roughly $24–$25 per share.
Surrozen posted a major earnings miss, reporting EPS of ($7.59) versus estimates of ($1.29) and revenue of $0.53M, even as the stock was up ~4.6% and the company has a market cap near $224M.

Surrozen, Inc. (NASDAQ:SRZN - Get Free Report) major shareholder Tcg Crossover Gp Ii, Llc acquired 15,223 shares of the business's stock in a transaction dated Monday, March 23rd. The stock was acquired at an average price of $24.90 per share, with a total value of $379,052.70. Following the completion of the transaction, the insider directly owned 683,225 shares of the company's stock, valued at approximately $17,012,302.50. This represents a 2.28% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.

Tcg Crossover Gp Ii, Llc also recently made the following trade(s):

On Tuesday, March 24th, Tcg Crossover Gp Ii, Llc bought 106,658 shares of Surrozen stock. The shares were acquired at an average cost of $24.69 per share, with a total value of $2,633,386.02.
On Monday, March 16th, Tcg Crossover Gp Ii, Llc bought 1,190 shares of Surrozen stock. The shares were acquired at an average price of $24.99 per share, for a total transaction of $29,738.10.
On Friday, March 13th, Tcg Crossover Gp Ii, Llc purchased 35,433 shares of Surrozen stock. The stock was bought at an average cost of $24.88 per share, for a total transaction of $881,573.04.
On Thursday, March 12th, Tcg Crossover Gp Ii, Llc purchased 12,374 shares of Surrozen stock. The stock was bought at an average cost of $24.99 per share, with a total value of $309,226.26.
On Thursday, February 12th, Tcg Crossover Gp Ii, Llc purchased 1,093 shares of Surrozen stock. The stock was bought at an average cost of $23.86 per share, with a total value of $26,078.98.
On Wednesday, February 11th, Tcg Crossover Gp Ii, Llc acquired 17,763 shares of Surrozen stock. The shares were bought at an average price of $23.57 per share, with a total value of $418,673.91.
On Tuesday, February 3rd, Tcg Crossover Gp Ii, Llc acquired 4,355 shares of Surrozen stock. The shares were bought at an average cost of $21.94 per share, for a total transaction of $95,548.70.
On Monday, February 2nd, Tcg Crossover Gp Ii, Llc bought 731 shares of Surrozen stock. The stock was bought at an average price of $21.38 per share, for a total transaction of $15,628.78.
On Friday, January 30th, Tcg Crossover Gp Ii, Llc bought 4,271 shares of Surrozen stock. The shares were bought at an average cost of $21.39 per share, with a total value of $91,356.69.

Surrozen Stock Up 4.6%

SRZN stock opened at $26.14 on Thursday. Surrozen, Inc. has a 52 week low of $5.90 and a 52 week high of $29.59. The firm has a 50-day simple moving average of $24.34 and a 200-day simple moving average of $18.81. The stock has a market capitalization of $224.02 million, a P/E ratio of -0.78 and a beta of 0.53.

Surrozen (NASDAQ:SRZN - Get Free Report) last issued its quarterly earnings results on Monday, March 23rd. The company reported ($7.59) earnings per share for the quarter, missing analysts' consensus estimates of ($1.29) by ($6.30). Surrozen had a negative net margin of 7,476.67% and a negative return on equity of 1,240.42%. The company had revenue of $0.53 million during the quarter, compared to analysts' expectations of $0.66 million. On average, analysts expect that Surrozen, Inc. will post -8.49 earnings per share for the current year.

Trending Headlines about Surrozen

Here are the key news stories impacting Surrozen this week:

Positive Sentiment: Major shareholder TCG Crossover GP II purchased 106,658 shares on March 24 at an average $24.69, increasing its stake ~16.9% to 736,554 shares — a strong insider-buy signal that can support the stock. SEC Filing
Positive Sentiment: TCG Crossover also bought 15,223 shares on March 23 at ~$24.90, a smaller follow-on purchase that further signals insider confidence. SEC Filing
Positive Sentiment: Cantor Fitzgerald reaffirmed an “overweight” rating with a $40 price target — a materially higher valuation that may attract buyers. Benzinga
Positive Sentiment: HC Wainwright reiterated a “Buy” rating and raised its target to $36. Its analyst also issued a FY2030 EPS forecast (-$3.54), notably less negative than the broader consensus, signaling a more optimistic long-term view. TickerReport
Neutral Sentiment: Short-interest reports for March show zero shorted shares and a 0.0 days-to-cover metric, but the entries include NaN and look inconsistent — treat this as unreliable data rather than a clear market signal.

Analyst Upgrades and Downgrades

SRZN has been the topic of a number of research analyst reports. Wall Street Zen raised Surrozen to a "sell" rating in a research note on Friday, November 28th. HC Wainwright reissued a "buy" rating and issued a $36.00 price objective (up from $32.00) on shares of Surrozen in a research note on Tuesday. Cantor Fitzgerald restated an "overweight" rating and issued a $40.00 price objective on shares of Surrozen in a report on Tuesday. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Surrozen in a report on Thursday, January 22nd. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Surrozen has an average rating of "Moderate Buy" and an average target price of $38.00.

Get Our Latest Stock Report on Surrozen

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Ikarian Capital LLC acquired a new position in shares of Surrozen during the 4th quarter worth approximately $1,487,000. Quadrature Capital Ltd acquired a new stake in shares of Surrozen in the fourth quarter valued at approximately $335,000. Millennium Management LLC lifted its position in Surrozen by 557.1% during the fourth quarter. Millennium Management LLC now owns 721,266 shares of the company's stock worth $16,301,000 after buying an additional 611,497 shares in the last quarter. Eversept Partners LP lifted its position in Surrozen by 23.8% during the fourth quarter. Eversept Partners LP now owns 95,286 shares of the company's stock worth $2,153,000 after buying an additional 18,289 shares in the last quarter. Finally, Balyasny Asset Management L.P. boosted its stake in Surrozen by 169.3% during the fourth quarter. Balyasny Asset Management L.P. now owns 190,489 shares of the company's stock worth $4,305,000 after buying an additional 119,757 shares during the last quarter. 66.57% of the stock is owned by hedge funds and other institutional investors.

About Surrozen

(Get Free Report)

Surrozen, Inc is a clinical-stage biopharmaceutical company focused on developing novel therapeutic antibodies that target the Wnt signaling pathway for applications in tissue repair, regeneration and oncology. Founded in 2012 and headquartered in South San Francisco, California, the company leverages its proprietary SurroBody platform to design bispecific antibody molecules capable of modulating Wnt receptor activity with enhanced tissue specificity.

The SurroBody platform enables the generation of high-affinity, dual-binding antibodies engineered to either activate or inhibit Wnt signaling, a pathway critical to cell proliferation, differentiation and homeostasis.